Brevan Howard Capital Management LP Syndax Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q2 2025
A detailed history of Brevan Howard Capital Management LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 28,227 shares of SNDX stock, worth $377,959. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,227
Previous 60,337
53.22%
Holding current value
$377,959
Previous $741,000
64.37%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding SNDX
# of Institutions
252Shares Held
100MCall Options Held
1.28MPut Options Held
1.29M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$114 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$106 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$77.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.03MShares$67.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$54.4 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $757M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...